Rumalon solution 1ml ampoules, 25pcs

Composition

1 amp. contains glycosaminoglycan-peptide complex 1 ml

Pharmacological action

A drug that regulates the metabolism of cartilage tissue

Indications

Degenerative-dystrophic diseases of the joints:

— gonarthrosis—

– arthrosis of the interdigital joints;

– coxarthrosis;

– spondylosis

— – spondyloarthrosis

— – meniscopathy;

– chondromalacia patella.

Contraindications

-hypersensitivity to the components of the drug;

– rheumatoid arthritis;

– age up to 18 years;

– pregnancy;

– breastfeeding;

– use in women of reproductive age who do not follow reliable methods of contraception.

Side effects

Determination of the frequency of adverse reactions (according to the WHO classification): very common (≥1/10), common (≥1/100 to <1/10), infrequent (≥1/1000 to <1/100), rare (≥1/10 000 to <1/1000), very rare (.

From the immune system:  rarely-allergic reactions, including anaphylactoid reactions, anaphylactic shock.

If these or any other side effects occur, the patient should stop using the drug and inform the attending physician.

Interaction

The drug Rumalon can be used simultaneously with NSAIDs and corticosteroids.

When used concomitantly with indirect anticoagulants, antiplatelet agents and fibrinolytics, their effect may be enhanced.

How to take, course of use and dosage

The drug is administered deep in / m: on the 1st day-0.3 ml, on the 2nd day-0.5 ml and then 3 times a week for 1 ml for 5-6 weeks.

Repeat the course of treatment – after consulting a doctor according to the same scheme.

Overdose

So far, no overdose cases have been reported.

Special instructions

When used concomitantly with indirect anticoagulants, antiplatelet agents and fibrinolytics, frequent monitoring of blood clotting parameters is necessary.

Influence on the ability to drive vehicles and mechanisms

The use of the drug does not affect the ability to perform potentially dangerous activities that require increased concentration of attention and speed of psychomotor reactions (driving vehicles, working with moving mechanisms, working as a dispatcher and operator).

Form of production

Solution for intravenous use from pale yellow with a brownish tinge to yellowish-brown, transparent, with the smell of metacresol.

Active ingredient

Glycosaminoglycan-Peptide Complex

Conditions of release from pharmacies

By prescription

Dosage form

solution for injection